Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

A new delivery system makes Curcumin more effective and safer against viruses.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

Five FDA-approved drugs may help block COVID-19 virus entry.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

Children with chilblain-like lesions may have a link to COVID-19.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Normal human melanocytes can avoid cell death through multiple pathways.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Overexpressing CtBP1 in skin cells causes skin and hair problems.